share_log

Novo Integrated Sciences | 8-K: Current report

ノボ・インテグレーテッド・サイエンシズ | 8-K:臨時報告書

SEC announcement ·  03/18 15:35
Moomoo AIのまとめ
Novo Integrated Sciences, Inc. reported on March 18, 2024, that it has entered into an Assignment of Security Purchase Agreement and Promissory Note with RC Consulting Group LLC and RC Consulting Consortium Group LLC. This assignment involves the transfer of all rights and interests in a previously agreed securities purchase agreement and an unsecured 15-year promissory note, originally issued on April 26, 2023, with a principal sum of $70,000,000. The note, which matures on April 26, 2038, includes a yield of 1.52% per annum and contains standard events of default provisions. The company also addressed a prior notification from Nasdaq on February 9, 2024, indicating non-compliance with minimum bid price requirements, which was considered an event of default under the terms of the securities purchase agreement and the note. However, a Limited Waiver was agreed upon with the Holder to exempt any non-compliance related to the minimum bid price requirement. The assignment does not affect the terms of the securities purchase agreement and the note, which remain in full force and effect, except as amended by the waiver.
Novo Integrated Sciences, Inc. reported on March 18, 2024, that it has entered into an Assignment of Security Purchase Agreement and Promissory Note with RC Consulting Group LLC and RC Consulting Consortium Group LLC. This assignment involves the transfer of all rights and interests in a previously agreed securities purchase agreement and an unsecured 15-year promissory note, originally issued on April 26, 2023, with a principal sum of $70,000,000. The note, which matures on April 26, 2038, includes a yield of 1.52% per annum and contains standard events of default provisions. The company also addressed a prior notification from Nasdaq on February 9, 2024, indicating non-compliance with minimum bid price requirements, which was considered an event of default under the terms of the securities purchase agreement and the note. However, a Limited Waiver was agreed upon with the Holder to exempt any non-compliance related to the minimum bid price requirement. The assignment does not affect the terms of the securities purchase agreement and the note, which remain in full force and effect, except as amended by the waiver.
2024年3月18日、Novo Integrated Sciences, Inc.は、RC Consulting Group LLCとRC Consulting Consortium Group LLCとの間でセキュリティ購入契約および約束手形の譲渡契約に署名したことを発表しました。この譲渡には、以前に合意された証券購入契約および4月26日に発行された元本7000万ドルの15年間の無担保約束手形のすべての権利と利益の譲渡が含まれます。手形は、2038年4月26日に満期を迎え、年率1.52%の利回りを含み、標準的な債務不履行条項が含まれています。同社はまた、2024年2月9日のNasdaqからの...すべて展開
2024年3月18日、Novo Integrated Sciences, Inc.は、RC Consulting Group LLCとRC Consulting Consortium Group LLCとの間でセキュリティ購入契約および約束手形の譲渡契約に署名したことを発表しました。この譲渡には、以前に合意された証券購入契約および4月26日に発行された元本7000万ドルの15年間の無担保約束手形のすべての権利と利益の譲渡が含まれます。手形は、2038年4月26日に満期を迎え、年率1.52%の利回りを含み、標準的な債務不履行条項が含まれています。同社はまた、2024年2月9日のNasdaqからの事前通知にも対応し、最低買気配価格要件の遵守に関する非遵守が証券購入契約および手形の条項に違反する事象と見なされたが、ホルダーと合意された限定的な免除により、最低買気配価格要件に関する非遵守が免除されました。この譲渡は、免除によって修正された以外は、証券購入契約および手形の条件に影響を与えず、完全に有効です。
これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報